The DOI matches its Crossref record; 78 of the 78 references it cites were found in a registry or an index.
Cytotoxicity of Dendrimers
Open accessAbstract
Drug delivery systems are molecular platforms in which an active compound is packed into or loaded on a biocompatible nanoparticle. Such a solution improves the activity of the applied drug or decreases its side effects. Dendrimers are promising molecular platforms for drug delivery due to their unique properties. These macromolecules are known for their defined size, shape, and molecular weight, as well as their monodispersity, the presence of the void space, tailorable structure, internalization by cells, selectivity toward cells and intracellular components, protection of guest molecules, and controllable release of the cargo. Dendrimers were tested as carriers of various molecules and, simultaneously, their toxicity was examined using different cell lines. It was discovered that, in general, dendrimer cytotoxicity depended on the generation, the number of surface groups, and the nature of terminal moieties (anionic, neutral, or cationic). Higher cytotoxicity occurred for higher-generation dendrimers and for dendrimers with positive charges on the surface. In order to decrease the cytotoxicity of dendrimers, scientists started to introduce different chemical modifications on the periphery of the nanomolecule. Dendrimers grafted with polyethylene glycol (PEG), acetyl groups, carbohydrates, and other moieties did not affect cell viability, or did so only slightly, while still maintaining other advantageous properties. Dendrimers clearly have great potential for wide utilization as drug and gene carriers. Moreover, some dendrimers have biological properties per se, being anti-fungal, anti-bacterial, or toxic to cancer cells without affecting normal cells. Therefore, intrinsic cytotoxicity is a comprehensive problem and should be considered individually depending on the potential destination of the nanoparticle.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A New Class of Polymers: Starburst-Dendritic Macromolecules
Tomalia, D. A., Baker, H., Dewald, J., Hall, M., Kallos, G., Martin, S., Roeck, J., Ryder, J., & Smith, P. (1985) · Polymer Journal · doi:10.1295/polymj.17.117 · Cited by 3,904
"Cascade"- and "Nonskid-Chain-like" Syntheses of Molecular Cavity Topologies
BUHLEIER, E., WEHNER, W., & VÖGTLE, F. (1978) · Synthesis · doi:10.1055/s-1978-24702 · Cited by 1,285
Dendrimers: synthesis, applications, and properties
Abbasi, E., Aval, S. F., Akbarzadeh, A., Milani, M., Nasrabadi, H. T., Joo, S. W., Hanifehpour, Y., Nejati-Koshki, K., & Pashaei-Asl, R. (2014) · Nanoscale Research Letters · doi:10.1186/1556-276x-9-247 · Cited by 1,279
Tam, J. P. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.15.5409 · Cited by 1,251
Malik, N., Wiwattanapatapee, R., Klopsch, R., Lorenz, K., Frey, H., Weener, J. W., Meijer, E. W., Paulus, W., & Duncan, R. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00246-1 · Cited by 1,227
Micelles. Part 1. Cascade molecules: a new approach to micelles. A [27]-arborol
Newkome, G. R., Yao, Z., Baker, G. R., & Gupta, V. K. (1985) · The Journal of Organic Chemistry · doi:10.1021/jo00211a052 · Cited by 1,199
Functional dendrimers, hyperbranched and star polymers
Inoue, K. (2000) · Progress in Polymer Science · doi:10.1016/s0079-6700(00)00011-3 · Cited by 879
The influence of surface modification on the cytotoxicity of PAMAM dendrimers
Jevprasesphant, R. (2003) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00623-3 · Cited by 726
Dendrimer‐based metal chelates: A new class of magnetic resonance imaging contrast agents
Wiener, E., Brechbiel, M. W., Brothers, H., Magin, R. L., Gansow, O. A., Tomalia, D. A., & Lauterbur, P. C. (1994) · Magnetic Resonance in Medicine · doi:10.1002/mrm.1910310102 · Cited by 718
Dendrimers in drug delivery and targeting: Drug-dendrimer interactions and toxicity issues
Pandita, D., Madaan, K., Kumar, S., Poonia, N., & Lather, V. (2014) · Journal of Pharmacy And Bioallied Sciences · doi:10.4103/0975-7406.130965 · Cited by 679
Dendrimers: properties and applications.
Klajnert, B., & Bryszewska, M. (2001) · Acta Biochimica Polonica · doi:10.18388/abp.2001_5127 · Cited by 526
Multifunctional dendritic polymers in nanomedicine: opportunities and challenges
Khandare, J., Calderón, M., Dagia, N. M., & Haag, R. (2012) · Chem. Soc. Rev. · doi:10.1039/c1cs15242d · Cited by 418
Dendrimer-platinate: a novel approach to cancer chemotherapy.
Malik, N., Evagorou, E. G., & Duncan, R. (1999) · PubMed · Cited by 417
Dendrimer−Silver Complexes and Nanocomposites as Antimicrobial Agents
Balogh, L., Swanson, D. R., Tomalia, D. A., Hagnauer, G. L., & McManus, A. T. (2001) · Nano Letters · doi:10.1021/nl005502p · Cited by 412
Drug complexation, in vitro release and cellular entry of dendrimers and hyperbranched polymers
Kolhe, P. (2003) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(03)00225-4 · Cited by 412
Dendrimer-platinate: a novel approach to cancer chemotherapy
Malik, N., Evagorou, E. G., & Duncan, R. (1999) · Anti-Cancer Drugs · doi:10.1097/00001813-199909000-00010 · Cited by 402
Wang, F., Bronich, T. K., Kabanov, A. V., Rauh, R. D., & Roovers, J. (2005) · Bioconjugate Chemistry · doi:10.1021/bc049784m · Cited by 317
The use of PAMAM dendrimers in the efficient transfer of genetic material into cells
Eichman, J. D., Bielinska, A. U., Kukowska-Latallo, J. F., & Baker, J. R. (2000) · Pharmaceutical Science & Technology Today · doi:10.1016/s1461-5347(00)00273-x · Cited by 313
Fast and Convenient Divergent Synthesis of Aliphatic Ester Dendrimers by Anhydride Coupling
Ihre, H., Padilla De Jesús, O. L., & Fréchet, J. M. J. (2001) · Journal of the American Chemical Society · doi:10.1021/ja010524e · Cited by 296
PAMAM dendrimers as promising nanocarriers for RNAi therapeutics
Kesharwani, P., Banerjee, S., Gupta, U., Mohd Amin, M. C. I., Padhye, S., Sarkar, F. H., & Iyer, A. K. (2015) · Materials Today · doi:10.1016/j.mattod.2015.06.003 · Cited by 290
Gillies, E. R., Dy, E., Fréchet, J. M. J., & Szoka, F. C. (2005) · Molecular Pharmaceutics · doi:10.1021/mp049886u · Cited by 265
Engineering of Dendrimer Surfaces to Enhance Transepithelial Transport and Reduce Cytotoxicity
Jevprasesphant, R., Penny, J., Attwood, D., McKeown, N. B., & D'Emanuele, A. (2003) · Pharmaceutical Research · doi:10.1023/a:1026166729873 · Cited by 256
Khandare, J. J., Jayant, S., Singh, A., Chandna, P., Wang, Y., Vorsa, N., & Minko, T. (2006) · Bioconjugate Chemistry · doi:10.1021/bc060240p · Cited by 226
Bourne, N., Stanberry, L. R., Kern, E. R., Holan, G., Matthews, B. R., & Bernstein, D. I. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.9.2471-2474.2000 · Cited by 204
Dendrimer Internalization and Intracellular Trafficking in Living Cells
Albertazzi, L., Serresi, M., Albanese, A., & Beltram, F. (2010) · Molecular Pharmaceutics · doi:10.1021/mp9002464 · Cited by 194
Agashe, H. B., Dutta, T., Garg, M., & Jain, N. K. (2006) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.58.11.0010 · Cited by 185
Cancer targeting potential of some ligand-anchored poly(propylene imine) dendrimers: a comparison
Kesharwani, P., Tekade, R. K., Gajbhiye, V., Jain, K., & Jain, N. K. (2011) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2010.10.010 · Cited by 184
Han, L., Huang, R., Liu, S., Huang, S., & Jiang, C. (2010) · Molecular Pharmaceutics · doi:10.1021/mp100185f · Cited by 182
Feliu, N., Walter, M. V., Montañez, M. I., Kunzmann, A., Hult, A., Nyström, A., Malkoch, M., & Fadeel, B. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2011.11.054 · Cited by 175
Mechanistic studies of in vitro cytotoxicity of poly(amidoamine) dendrimers in mammalian cells
Mukherjee, S. P., Lyng, F. M., Garcia, A., Davoren, M., & Byrne, H. J. (2010) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2010.08.016 · Cited by 172
Launay, N., Caminade, A.-M., & Majoral, J.-P. (1995) · Journal of the American Chemical Society · doi:10.1021/ja00116a037 · Cited by 171
Structure Activity Relationship of Dendrimer Microbicides with Dual Action Antiviral Activity
Tyssen, D., Henderson, S. A., Johnson, A., Sterjovski, J., Moore, K., La, J., Zanin, M., Sonza, S., Karellas, P., Giannis, M. P., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012309 · Cited by 169
Han, M., Lv, Q., Tang, X.-J., Hu, Y.-L., Xu, D.-H., Li, F.-Z., Liang, W.-Q., & Gao, J.-Q. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.08.020 · Cited by 167
Mukherjee, S. P., Davoren, M., & Byrne, H. J. (2009) · Toxicology in Vitro · doi:10.1016/j.tiv.2009.09.014 · Cited by 157
Cytotoxicity of Polypropylenimine Dendrimer Conjugates on Cultured Endothelial Cells
Stasko, N., Johnson, C. B., Schoenfisch, M. H., Johnson, T. A., & Holmuhamedov, E. (2007) · Biomacromolecules · doi:10.1021/bm7008203 · Cited by 156
Delivery of paclitaxel across cellular barriers using a dendrimer-based nanocarrier
Teow, H. M., Zhou, Z., Najlah, M., Yusof, S. R., Abbott, N. J., & D’Emanuele, A. (2012) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.10.024 · Cited by 155
Polyether based amphiphiles for delivery of active components
Gupta, S., Tyagi, R., Parmar, V. S., Sharma, S. K., & Haag, R. (2012) · Polymer · doi:10.1016/j.polymer.2012.04.047 · Cited by 132
Phosphorus Dendrimers Affect Alzheimer’s (Aβ1–28) Peptide and MAP-Tau Protein Aggregation
Wasiak, T., Йонов, М., Nieznański, K., Nieznańska, H., Klementieva, O. L., Granell, M., Cladera, J., Majoral, J., Caminade, A., & Klajnert‐Maculewicz, B. (2011) · Molecular Pharmaceutics · doi:10.1021/mp2005627 · Cited by 132
Self-citationAppelhans, D., Klajnert‐Maculewicz, B., Janaszewska, A., Łaźniewska, J., & Voit, B. I. (2014) · Chemical Society Reviews · doi:10.1039/c4cs00339j · Cited by 122
Self-citationStructure-biocompatibility relationship of dendritic polyglycerol derivatives
Khandare, J. J., Mohr, A., Calderón, M., Welker, P., Licha, K., & Haag, R. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.02.001 · Cited by 122
Surface modification of PAMAM dendrimer improves its biocompatibility
Ciołkowski, M., Petersen, J. F., Ficker, M., et al. (2012) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2012.03.009 · Cited by 120
Wen, Y., Guo, Z., Du, Z., Fang, R., Wu, H., Zeng, X., Wang, C., Feng, M., & Pan, S. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.07.032 · Cited by 109
Ligand anchored dendrimers based nanoconstructs for effective targeting to cancer cells
Gupta, U. D., Dwivedi, S. K. D., Bid, H. K., Konwar, R., & Jain, N. K. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.04.002 · Cited by 107
Fuchs, S., Kapp, T., Otto, H., Schöneberg, T., Franke, P., Gust, R., & Schlüter, A. D. (2004) · Chemistry - A European Journal · doi:10.1002/chem.200305386 · Cited by 107
Klementieva, O. L., Benseny‐Cases, N., Gella, A., Appelhans, D., Voit, B. I., & Cladera, J. (2011) · Biomacromolecules · doi:10.1021/bm2008636 · Cited by 105
Brahmi, N. E., Kazzouli, S. E., Mignani, S. M., Essassi, E. M., Aubert, G., Laurent, R., Caminade, A., Bousmina, M., Cresteil, T., & Majoral, J. (2013) · Molecular Pharmaceutics · doi:10.1021/mp4000184 · Cited by 102
Choi, Y. J., Kang, S. J., Kim, Y. J., Lim, Y., & Chung, H. W. (2010) · Drug and Chemical Toxicology · doi:10.3109/01480540903493507 · Cited by 99
Mukherjee, S. P., & Byrne, H. J. (2012) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2012.05.002 · Cited by 97
Rompicharla, S. V. K., Kumari, P., Bhatt, H., et al. (2018) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2018.12.069 · Cited by 90
Boas, U., Karlsson, A. J., de Waal, B. F. M., & Meijer, E. W. (2001) · The Journal of Organic Chemistry · doi:10.1021/jo001573x · Cited by 89
Dendrimers Bind Antioxidant Polyphenols and cisPlatin Drug
Abderrezak, A., Bourassa, P., Mandeville, J. S., Sedaghat‐Herati, R., & Tajmir‐Riahi, H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033102 · Cited by 84
Zeng, X., Zhang, Y., & Nyström, A. M. (2012) · Biomacromolecules · doi:10.1021/bm301281k · Cited by 84
Viologen-Phosphorus Dendrimers Inhibit α-Synuclein Fibrillation
Miłowska, K., Grochowina, J., Katir, N., Kadib, A. E., Majoral, J., Bryszewska, M. J., & Gabryelak, T. (2013) · Molecular Pharmaceutics · doi:10.1021/mp300636h · Cited by 75
Biological properties of low molecular mass peptide dendrimers
Klajnert‐Maculewicz, B., Janiszewska, J., Urbańczyk-Lipkowska, Z., Bryszewska, M. J., Shcharbin, D., & Łabieniec, M. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.10.039 · Cited by 70
Self-citationJanaszewska, A., Maczynska, K., Matuszko, G., Appelhans, D., Voit, B. I., Klajnert‐Maculewicz, B., & Bryszewska, M. J. (2011) · New Journal of Chemistry · doi:10.1039/c1nj20489k · Cited by 69
Self-citationZhang, Y., Thomas, T. P., Lee, K.-H., Li, M., Zong, H., Desai, A. M., Kotlyar, A., Huang, B., Holl, M. M. B., & Baker, J. R. (2011) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2011.03.019 · Cited by 67
A rational design of synthetic peptide vaccine with a built‐in adjuvant
Defoort, J.-P., Nardelli, B., Huang, W., & Tam, J. P. (1992) · International journal of peptide & protein research · doi:10.1111/j.1399-3011.1992.tb00294.x · Cited by 67
Dendrimers reduce toxicity of Aβ 1-28 peptide during aggregation and accelerate fibril formation
Klajnert‐Maculewicz, B., Wasiak, T., Йонов, М., Fernandez‐Villamarin, M., Sousa‐Herves, A., Correa, J., Riguera, R., & Fernández-Megía, E. (2012) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2012.03.005 · Cited by 65
Self-citationJanaszewska, A., Ciołkowski, M., Wróbel, D., Petersen, J. F., Ficker, M., Christensen, J. B., Bryszewska, M. J., & Klajnert‐Maculewicz, B. (2013) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2013.01.010 · Cited by 63
Self-citationLy, T. U., Trân, N. Q., Hoang, T. K. D., Phan, K. N., Truong, H. N., & Nguyen, C. K. (2013) · Journal of Biomedical Nanotechnology · doi:10.1166/jbn.2013.1479 · Cited by 63
Jia, L., Xu, J., Wang, H., & Ji, J. (2010) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2010.12.012 · Cited by 57
Wang, F., Cai, X., Su, Y., Hu, J., Wu, Q., Zhang, H., Xiao, J., & Cheng, Y. (2012) · Acta Biomaterialia · doi:10.1016/j.actbio.2012.07.031 · Cited by 57
Antimicrobial activity of poly(propylene imine) dendrimers
Felczak, A., Wrońska, N., Janaszewska, A., Klajnert‐Maculewicz, B., Bryszewska, M. J., Appelhans, D., Voit, B. I., Różalska, S., & Lisowska, K. (2012) · New Journal of Chemistry · doi:10.1039/c2nj40421d · Cited by 55
Self-citationKrishnamoorthy, K., Babu, A., Kim, S., Murugesan, R., & Jeyasubramanian, K. (2011) · Cancer Nanotechnology · doi:10.1007/s12645-011-0019-3 · Cited by 54
Thiagarajan, G., Ray, A., Malugin, A., & Ghandehari, H. (2010) · Pharmaceutical Research · doi:10.1007/s11095-010-0179-6 · Cited by 51
Dendritic Molecular Transporters Provide Control of Delivery to Intracellular Compartments
Huang, K., Voss, B., Kumar, D., Hamm, H. E., & Harth, E. M. (2007) · Bioconjugate Chemistry · doi:10.1021/bc060287a · Cited by 51
Hofman, J., Bunček, M., Haluza, R., Streinz, L., Ledvina, M., & Cígler, P. (2012) · Macromolecular Bioscience · doi:10.1002/mabi.201200303 · Cited by 45
Enhancement of Cytotoxicity by Combining Pyrenyl-Dendrimers and Arene Ruthenium Metallacages
Pitto‐Barry, A., Zava, O., Dyson, P. J., Deschenaux, R., & Therrien, B. (2012) · Inorganic Chemistry · doi:10.1021/ic202739d · Cited by 43
Mechanism of Cationic Phosphorus Dendrimer Toxicity against Murine Neural Cell Lines
Łaźniewska, J., Miłowska, K., Zabłocka, M., Mignani, S. M., Caminade, A., Majoral, J., Bryszewska, M. J., & Gabryelak, T. (2013) · Molecular Pharmaceutics · doi:10.1021/mp4003255 · Cited by 41
Ota, S., Ono, T., Morita, A., Uenaka, A., Harada, M., & Nakayama, E. (2002) · PubMed · Cited by 39
Ottaviani, M. F., Mazzeo, R., Cangiotti, M., Fiorani, L., Majoral, J., Caminade, A., Pędziwiatr‐Werbicka, E., Bryszewska, M. J., & Klajnert‐Maculewicz, B. (2010) · Biomacromolecules · doi:10.1021/bm100824z · Cited by 38
Self-citationMultivalent Dendrimer Vectors with DNA Intercalation Motifs for Gene Delivery
Wong, P. T., Tang, K., Coulter, A., Tang, S., Baker, J. R., & Choi, S. K. (2014) · Biomacromolecules · doi:10.1021/bm501169s · Cited by 37
Phosphorus dendrimers: from synthesis to applications
Caminade, A., Maraval, V., Laurent, R., Turrin, C., Sutra, P., Leclaire, J., Griffe, L., Marchand, P., Baudoin‐Dehoux, C., Rebout, C., et al. (2003) · Comptes Rendus Chimie · doi:10.1016/j.crci.2003.04.009 · Cited by 34
Mechanism of PAMAM Dendrimers Internalization in Hippocampal Neurons
Vidal, F., Vásquez, P., Díaz, C. F., Nova-Baza, D., Alderete, J. B., & Guzmán, L. (2016) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.6b00381 · Cited by 33
Yellepeddi, V., Vangara, K. K., & Palakurthi, S. (2013) · Journal of Nanoparticle Research · doi:10.1007/s11051-013-1897-6 · Cited by 32
Uram, Ł. S., Szuster, M., Filipowicz-Rachwał, A., Zaręba, M., Wałajtys-Rode, E., & Wołowiec, S. (2016) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2016.11.047 · Cited by 32
Hernando, M. D., Rosenkranz, P., Ulaszewska, M., Fernández‐Cruz, M. L., Fernández‐Alba, A. R., & Navas, J. M. (2012) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-012-6256-4 · Cited by 16
Laumann, K., Boas, U., Larsen, H. M., Heegaard, P. M. H., & Bergström, A. (2014) · Biomacromolecules · doi:10.1021/bm501244m · Cited by 14
Cited by
Applications and Limitations of Dendrimers in Biomedicine
Chis, A. A., Dobrea, C., Morgovan, C., Arseniu, A. M., Rus, L. L., Butuca, A., Juncan, A. M., Totan, M., Vonica-Tincu, A. L., Cormos, G., et al. (2020) · Molecules · doi:10.3390/molecules25173982 · Cited by 467
Ahlawat, J., Guillama Barroso, G., Masoudi Asil, S., Alvarado, M., Armendariz, I., Bernal, J., Carabaza, X., Chavez, S., Cruz, P., Escalante, V., et al. (2020) · ACS Omega · doi:10.1021/acsomega.0c01592 · Cited by 274
Moorthy, H., & Govindaraju, T. (2021) · ACS Applied Bio Materials · doi:10.1021/acsabm.0c01319 · Cited by 64
Nájera-Maldonado, L., Parra-González, M., Peralta-Cuevas, E., Gutierrez-Onofre, A. J., Garcia-Atutxa, I., & Villanueva-Flores, F. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17091169 · Cited by 40
Nanomaterial Nitric Oxide Delivery in Traumatic Orthopedic Regenerative Medicine
Anastasio, A. T., Paniagua, A., Diamond, C., Ferlauto, H. R., & Fernandez-Moure, J. S. (2021) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.592008 · Cited by 25
Metadata
- Authors
- Janaszewska, A., Lazniewska, J., Trzepiński, P., Marcinkowska, M., & Klajnert-Maculewicz, B.
- Venue
- Biomolecules
- Publisher
- MDPI AG
- Published
- 2019-08-01
- Volume
- 9
- Issue
- 8
- Pages
- 330
- ISSN
- 2218-273X (ISSN-L)
- OpenAlex
- W2806482318
- Cited by
- 409
- References
- 78
- FWCI
- 20.32
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.